In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $39.36, denoting a +1.84% change from the preceding trading day. We recently compiled a list of the Top 11 CRISPR ...

Shares of CRISPR Therapeutics have struggled amid less-than-stellar sales of its Casgevy therapy. The company's gene-editing biotechnology holds much promise but still faces significant uncertainties.

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

CRISPR-Cas9技术因其高效的基因编辑能力成为功能基因组学的重要工具。然而，传统CRISPR筛选在复杂的体内模型（in vivo）中常面临瓶颈效应与生物异质 ...

CRISPR-Cas系统是原核生物中广泛存在的一种由RNA引导靶向外源遗传物质的核酸免疫系统。基于II型CRISPR-Cas9的基因编辑技术，获得2020年诺贝尔化学奖，并在生物医药等诸多领域产生了革命性的影响。而III型CRISPR-Cas系统是目前发现的所有CRISPR-Cas系统中最复杂的一类 ...

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Haihe Laboratory of Cell Ecosystem, ...

1 Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto, Japan 2 Department of Neuroinnovation, Institute for Biomedical Sciences, Interdisciplinary Cluster ...

School of Biomedical Engineering, The International Peace Maternity and Child Health Hospital, Zhangjiang Institute for Advanced Study and National Center for Translational Medicine, Shanghai Jiao ...